WNK1 inhibitors
WO2025149622A1PCT designated stage expired Publication Date: 2025-07-17DANIA THERAPEUTICS APS
Patent Information
- Application Number
- PCT/EP2025/050550
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-01-10
- Filing Date
- 2025-01-10
- Publication Date
- 2025-07-17
Smart Images
Figure EP2025050550_17072025_PF_FP_ABST
Abstract
The present invention relates to novel compounds of formula (I), pharmaceutical compositions comprising such compounds and their use for treating, alleviating or preventing diseases or disorders relating to the activity of WNK1.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Methods
US20080286809A1
Targeting WNK1 in blood cancers
WO2021028438A1
Targeting WNK1 in blood cancers
EP3777857A1